Participants
RECRUITMENT
Participation from human subjects in the study occurred beginning with recruitment from October 29, 2018, to follow-up, ending June 15, 2020. A total of 93 participants were screened for study inclusion over a 6-month recruitment period, among whom 48 met study entry criteria and were randomized 1:1 into two treatment groups (Fig. 